As previously reported, using the Hey3Met2 human ovarian cancer cell line, we found the RNASET2 gene to possess a remarkable in vivo tumor suppressor activity, irrespective of the protein’s catalytic activity [9]. This evidence concerns the gene RNASET2 and ovarian carcinoma.